Efficacy and Safety of Empagliflozin in Type 2 Diabetes Mellitus Saudi Patients as Add-On to Antidiabetic Therapy: A Prospective, Open-Label, Observational Study

por Althobaiti, Fahad M., Alsanosi, Safaa M., Falemban, Alaa H., Alzahrani, Abdullah R., Fataha, Salma A., Salih, Sara O., Alrumaih, Ali M., Alotaibi, Khalid N., Althobaiti, Hazim M., Al-Ghamdi, Saeed S., Ayoub, Nahla
Publicado 2022